title: A survey of vitiligo management among dermatologists in Saudi Arabia.
abstract: BACKGROUND
  There are concerns that there is no uniform approach towards the management of vitiligo. Objectives To explore attitudes and strategies for the management of vitiligo among dermatologists.
  
  
  METHODS
  A self-administered questionnaire containing 22 questions was distributed to 160 dermatologists attending a national dermatology conference in 2007.
  
  
  RESULTS
  One hundred and twelve dermatologists responded to the questionnaire (70% response rate). We had 105 completed questionnaires (seven were excluded due to incompleteness). Active treatment of vitiligo was recommended by 96% in more than half of patients, while 79% recommended treatment at non-visible sites. Repigmentation was regarded as main treatment goal by 54%. Mid-potent topical steroids were widely prescribed for focal vitiligo (72% in children and 65% in adults). Use of tacrolimus and pimecrolimus was limited. The most common used phototherapy was 'narrowband ultraviolet B' (NBUVB; 36% and 40% for generaliased vitiligo in children and adults, respectively). The use of oral psoralen plus UVA (PUVA) was limited (8% for generalized vitiligo in adults). Few respondents (1-8% for different types of vitiligo) prescribed outdoor topical PUVA. Vitiligo surgery was advised mainly for segmental type (18% in adults and 5% in children). Depigmentation was the first option for universal vitiligo by 50% and 30% in adults and children, respectively.
  
  
  CONCLUSIONS
  Most dermatologists are enthusiastic about active treatment of vitiligo even in hidden sites. Overall, the most two common treatment modalities were topical steroids and NBUVB. Vitiligo surgery is underutilized. Development of national practice guidelines is needed.
authors.affiliation: Dermatology Department, Vitiligo Research Chair, College of Medicine, King Saud University, Riyadh, Saudi Arabia. kmgderm@yahoo.com
authors.forename: K M
authors.initials: KM
authors.lastname: AlGhamdi
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D003880:Dermatology; D006801:Humans; D011701:PUVA Therapy; D010342:Patient Acceptance of Health Care; D010818:Practice Patterns, Physicians'; D012529:Saudi Arabia; D011795:Surveys and Questionnaires; D014820:Vitiligo / Q000523:psychology / Q000628:therapy*; D000078329:Workforce
chemical_list: D000305:Adrenal Cortex Hormones